Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Casu C, Pettinato M, Liu A, Aghajan M, Lo Presti V, Lidonnici MR, Munoz KA, O'Hara E, Olivari V, Di Modica SM, Booten S, Guo S, Neil G, Miari R, Shapir N, Zafir-Lavie I, Domev H, Ferrari G, Sitara D, Nai A, Rivella S.
Casu C, et al. Among authors: rivella s.
Blood. 2020 Oct 22;136(17):1968-1979. doi: 10.1182/blood.2019004719.
Blood. 2020.
PMID: 32556142
Free PMC article.